Tudor Investment Corp’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-11,355
Closed -$107K 3480
2025
Q3
$107K Buy
+11,355
New +$108K ﹤0.01% 3258
2025
Q2
Sell
-13,628
Closed -$205K 3225
2025
Q1
$205K Sell
13,628
-22,361
-62% -$372K ﹤0.01% 2858
2024
Q4
$592K Buy
35,989
+6,647
+23% +$131K 0.01% 2107
2024
Q3
$725K Buy
29,342
+715
+2% +$18.5K 0.01% 1813
2024
Q2
$725K Sell
28,627
-7,420
-21% -$192K 0.01% 1629
2024
Q1
$916K Buy
36,047
+11,686
+48% +$283K 0.01% 1374
2023
Q4
$552K Sell
24,361
-11,670
-32% -$241K 0.01% 1746
2023
Q3
$671K Buy
+36,031
New +$747K 0.01% 1525
2021
Q2
Sell
-33,185
Closed -$1.35M 1585
2021
Q1
$1.35M Buy
33,185
+15,728
+90% +$597K 0.03% 696
2020
Q4
$790K Buy
17,457
+5,128
+42% +$195K 0.02% 773
2020
Q3
$436K Buy
+12,329
New +$445K 0.02% 870
2020
Q1
Sell
-30,702
Closed -$1.59M 1038
2019
Q4
$1.59M Buy
30,702
+12,915
+73% +$750K 0.08% 365
2019
Q3
$976K Buy
17,787
+11,001
+162% +$565K 0.04% 503
2019
Q2
$276K Buy
+6,786
New +$247K 0.01% 883
2018
Q2
Sell
-9,687
Closed -$482K 1031
2018
Q1
$482K Sell
9,687
-6,604
-41% -$373K 0.02% 584
2017
Q4
$878K Sell
16,291
-2,751
-14% -$152K 0.05% 398
2017
Q3
$1.1M Buy
19,042
+5,123
+37% +$268K 0.05% 354
2017
Q2
$687K Sell
13,919
-11,356
-45% -$523K 0.03% 463
2017
Q1
$1.1M Buy
25,275
+8,206
+48% +$392K 0.04% 345
2016
Q4
$836K Buy
17,069
+4,238
+33% +$196K 0.03% 448
2016
Q3
$614K Buy
+12,831
New +$634K 0.02% 629
2016
Q2
Sell
-4,911
Closed -$220K 1608
2016
Q1
$220K Buy
+4,911
New +$199K 0.01% 1460
2014
Q3
Sell
-6,759
Closed -$313K 1337
2014
Q2
$313K Sell
6,759
-3,894
-37% -$173K 0.02% 819
2014
Q1
$438K Buy
+10,653
New +$396K 0.03% 600

Other funds holding ANIK